Biotechnology firm Regeneron will purchase 23andMe out of chapter for $256 million, with a plan to maintain the DNA-testing firm working with out interruption and uphold its privateness safety guarantees.

In its announcement of the acquisition, Regeneron assured 23andMe’s 15 million clients that their knowledge—together with genetic and well being data, family tree, and different delicate private data—could be secure and in good arms. Regeneron goals to make use of the big trove of genetic knowledge to additional its personal work utilizing genetics to develop medical advances—one thing 23andMe tried and did not do.

“As a world chief in human genetics, Regeneron Genetics Middle is dedicated to and has a confirmed monitor document of safeguarding the genetic knowledge of individuals throughout the globe, and, with their consent, utilizing this knowledge to pursue discoveries that profit science and society,” Aris Baras, senior vice chairman and head of the Regeneron Genetics Middle, stated in a press release. “We guarantee 23andMe clients that we’re dedicated to defending the 23andMe dataset with our excessive requirements of information privateness, safety, and moral oversight and can advance its full potential to enhance human well being.”

Baras stated that Regeneron’s Genetic Middle already has its personal genetic dataset from practically 3 million individuals.

The security of 23andMe’s dataset has drawn appreciable concern amongst customers, lawmakers, and regulators amid the corporate’s downfall. As an example, in March, California Legal professional Normal Rob Bonta made the bizarre transfer to induce Californians to delete their genetic data amid 23andMe’s financial distress. Federal Trade Commission Chairman Andrew Ferguson additionally weighed in, making clear in a March letter that “any purchaser ought to expressly conform to be certain by and cling to the phrases of 23andMe’s privateness insurance policies and relevant legislation.”